Dipna Pharmachem responded to a BSE query on significant scrip price movement dated April 7, 2026.
The company stated it has no undisclosed price-sensitive information and is fully compliant with SEBI LODR regulations.
Attributed the stock price volatility to natural market forces and confirmed no reportable events are pending.